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Deregulation of DNA methylation has been recently
identified in malignant hematologic diseases such as
inactivation of the Ten-ElevenTranslocation 2 (TET2)
gene by haplo-insufficiency. Inactivating mutations of
TET2 were first described in myeloid disorders and
more recently in peripheral T-cell lymphomas especially
those that are harboring T follicular helper features like
angio-immunoblastic T cell lymphoma. In order to
determine new oncogenic pathways in Adult T cell leu-
kemia/lymphoma (ATLL) that could cooperate with
viral oncogenic proteins, we investigated the presence of
TET2 coding sequence mutations and their clinical rele-
vance in a retrospective cohort of 49 ATL patients. We
identify inactivating mutations of TET2 gene in 10
patients of 49 analyzed (20%). Of the 37 patients with
aggressive forms (acute and lymphoma), 9 (24%) had
TET2 mutations as only one (8%) of the 12 with indo-
lent forms had a TET2 mutation. This last patient had
nevertheless a poor outcome and died four years from
the diagnosis from relapse. In addition, five patients
show the same recurrent point mutation, which con-
ducts to the loss of coding sequence in one allele and
lead to haplo-insufficiency. Analysis of different clinical
cases suggests that TET2 mutation could be acquired at
different steps of the T cell oncogenesis and could even
in some cases precede HTLV-1 infection. Analysis of
viral integration is still ongoing. Here, we show that loss
of TET2 is frequently associated with ATLL and seems
to more frequent in aggressive forms.
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